Article
CDKN2A/p16 inactivation is related to pituitary adenoma type and size
1 Jan 2001
Abstract excerpt
p16 (CDKN2A, MTS1, INK4A) status at genomic and protein levels was analysed and correlated with clinico-pathological features in 72 pituitary adenomas. Methylation of CpG islands of promoter/exon 1 sequences was found in most gonadotroph, lactotroph, plurihormonal, and null cell adenomas (36 of 44, 82%), but it was rare in somatotroph (1 of 13 cases, 8%) and corticotroph adenomas (1 of 15 cases, 7%). Homozygous...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
